Biotech broker fined $5,000 for venting on Facebook

A financial watchdog has fined a broker $5,000 for comments he made about Arena Pharmaceuticals on Facebook. The broker's post called an article about Arena "idiotic," but failed to mention he--and 33 of his customers--owned stock in the biotech. Article

Suggested Articles

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

Elligo Health Research will test a harmonized real-word data model built by the FDA.

Just about a year after filing its IPO application BGI hits a big wall with a regulatory review.